Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

Background A relatively high mortality of severe coronavirus disease 2019 (COVID‐19) is worrying, and the application of heparin in COVID‐19 has been recommended by some expert consensus because of the risk of disseminated intravascular coagulation and venous thromboembolism. However, its efficacy r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of thrombosis and haemostasis Jg. 18; H. 5; S. 1094 - 1099
Hauptverfasser: Tang, Ning, Bai, Huan, Chen, Xing, Gong, Jiale, Li, Dengju, Sun, Ziyong
Format: Journal Article
Sprache:Englisch
Veröffentlicht: England Elsevier Limited 01.05.2020
International Society on Thrombosis and Haemostasis. Published by Elsevier Inc
Schlagworte:
ISSN:1538-7933, 1538-7836, 1538-7836
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!